PATENT CLAIM ANALYSIS

Application Number: 15951699
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "576000"]

Abstract:
The present invention involves the use of 2,4-disulfonyl phenyl tert-butyl nitrone (2,4-ds-PBN) in the treatment and prevention of gliomas. The 2,4-ds-PBN may be used alone or combined with other traditional chemo- and radiotherapies and surgery, to treat or prevent glioma occurrence, recurrence, spread, growth, metastasis, or vascularization.

Claim (Index 33):
The method of  claim 32 , wherein enteral administration is through dietary supplementation of a food component.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 91.0
- Lexical Diversity: 1.32558
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14159753', '15292324', '12552792', '13060191', '11491520']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8163274611728861
- 35 USC 102 Novelty (BERT): 0.5990743451557904
- Combined Prediction Score: 0.7946021495711766
- Mean Citation Score: 421.47978
- Max Citation Score: 555.52124
- Similarity Product: 449.05547668845423

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test